\-\ Texto\\:\\ \ \(0\)\
\-\ bitemporal\\ visual\\ field\\ defects\\.\ \(1\)\
\-\ ongoing\ \(26\)\
\-\ suprasellar\\ mass\\.\ \(4\)\
\-\ craniopharyngioma\ \(24\)\
\-\ craniopharyngioma\ \(24\)\
\-\ 37\\ y\\/o\\ female\\ with\\ 1\\ month\\ hx\\ of\\ recurrent\\ sharp\\,\\ right\\ temporal\\ ha\\ and\\ 2\\ week\\ hx\\ of\\ worsening\\ bitemporal\\ visual\\ field\\ defects\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ bitemporal\\:\\ 0\\.4392120023624399\ \(0\)\
\-\ craniopharyngioma\\:\\ 0\\.3466921246876906\ \(0\)\
\-\ field\\:\\ 0\\.3372390366719399\ \(0\)\
\-\ hx\\:\\ 0\\.3265063085278411\ \(0\)\
\-\ defects\\:\\ 0\\.3093423623704535\ \(0\)\
\-\ visual\\:\\ 0\\.3061393743465102\ \(0\)\
\-\ ha\\:\\ 0\\.20876038073459988\ \(0\)\
\-\ ongoing\\:\\ 0\\.19971245657505232\ \(0\)\
\-\ sharp\\:\\ 0\\.17647143821084238\ \(0\)\
\-\ suprasellar\\:\\ 0\\.17600548712998867\ \(0\)\
\-\ 37\\:\\ 0\\.1528474168297734\ \(0\)\
\-\ recurrent\\:\\ 0\\.14385491316509644\ \(0\)\
\-\ temporal\\:\\ 0\\.13781708424643738\ \(0\)\
\-\ worsening\\:\\ 0\\.1370036478013962\ \(0\)\
\-\ week\\:\\ 0\\.12067107189619947\ \(0\)\
\-\ month\\:\\ 0\\.1091363539030341\ \(0\)\
\-\ female\\:\\ 0\\.08657294727361564\ \(0\)\
\-\ of\\:\\ 0\\.07021895641801949\ \(0\)\
\-\ mass\\:\\ 0\\.06852931397809375\ \(0\)\
\-\ right\\:\\ 0\\.0594813898185462\ \(0\)\
\-\ and\\:\\ 0\\.03707260050723254\ \(0\)\
\-\ with\\:\\ 0\\.035130456113873505\ \(0\)\
